CorMatrix Cardiovascular has received US Food and Drug Administration (FDA) 510(k) clearance for its CorMatrix ECM, a device designed for pericardial closure and carotid tissue repair following endarterectomy and suture line buttressing.

CorMatrix ECM uses the company’s proprietary ECM technology, an extracellular matrix biomaterial which provides a natural bio-scaffold, enabling a patient’s own host cells to repopulate and repair damaged tissues.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The unique CorMatrix material helps stimulate tissue growth by providing a location where the patient’s cells can migrate and integrate, eventually creating new tissue in place of the CorMatrix ECM.

The CorMatrix implant is gradually replaced, as the patient’s own body reinforces and rebuilds the weakened site.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact